ADAM GALINDO: Open Payments
NPI 1144753112 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$697 in 48 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $217 · 2025 $697
Food & beverage: $697
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 20 | $192 |
| Merck Sharp & Dohme LLC | 8 | $136 |
| Amgen Inc. | 5 | $94 |
| Abbott Laboratories | 3 | $68 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $62 |
| ABIOMED | 2 | $53 |
| Boston Scientific Corporation | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Shockwave Medical, Inc | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $15 |
Products named: LEQVIO, VERQUVO, REPATHA, LifeVest, WATCHMAN FLX, PRESSUREWIRE, CAPVAXIVE, ESPRIT.
Industry payments across KS — which companies pay providers there.
